watersolubl
extract
ferment
polygonum
tinctorium
aiton
polygonacea
call
sukumo
exhibit
potent
inhibitori
activ
hiv
type
vitro
extract
potent
suppress
acut
iii
b
infect
cell
ec
valu
gml
exhibit
low
cytotox
cell
even
high
concentr
cc
gml
also
inhibit
giant
cell
format
cocultur
hivinfect
cell
uninfect
cell
sukumo
extract
found
interact
viral
envelop
glycoprotein
cellular
receptor
thu
block
viruscel
bind
virusinduc
syncytium
format
good
correl
extract
activ
inhibitori
effect
bind
also
suppress
replic
herp
simplex
viru
type
vero
cell
ec
gml
hand
appreci
activ
influenza
viru
polioviru
sar
corona
viru
test
concentr
rang
gml
shown
microscop
imag
analysi
cytopath
effect
cpe
physicochem
studi
reveal
antihiv
activ
extract
essenti
maintain
boil
c
hcl
naoh
treatment
mm
naio
inhibitori
activ
extract
also
reduc
pronas
digest
activ
factor
extract
like
novel
compound
polyanion
substructur
molecular
weight
one
logic
target
viral
life
cycl
inhibit
replic
step
process
infecti
virion
enter
host
cell
moor
stevenson
lin
et
al
therefor
identif
hiv
entri
inhibitor
serv
novel
antihiv
drug
urgent
need
retrovir
infect
initi
attach
virion
cell
surfac
even
occur
glycoprotein
viral
envelop
interact
specif
receptor
host
cell
trigger
fusion
great
varieti
polyanion
compound
describ
act
viru
adsorpt
inhibitor
class
compound
also
compris
cosalan
analogu
contain
polycarboxyl
pharmacophor
well
sulfat
polysaccharid
extract
sea
alga
nakashima
et
al
nakashima
et
al
santhosh
et
al
witvrouw
de
clercq
compound
assum
exert
antihiv
activ
shield
posit
charg
site
loop
region
viral
envelop
glycoprotein
interrupt
viru
attach
neg
charg
heparan
sulfat
proteoglycan
cell
surfac
inhibit
specif
bind
receptor
cell
compound
also
interfer
later
event
receptormedi
fusion
virtu
attach
compound
probabl
penetr
cell
mass
highli
anion
charg
rather
act
antivir
agent
imped
attach
subsequ
entri
viru
particl
cell
number
sulfat
polysaccharid
includ
dextran
sulfat
heparin
report
potenti
antivir
drug
sinc
inhibit
replic
varieti
virus
vitro
baba
et
al
bartolini
et
al
nakashima
et
al
ylisastigui
et
al
extent
inhibit
appear
depend
viral
strain
host
cell
type
dextran
sulfat
interfer
associ
detect
effect
interact
polyanion
readili
detect
wherea
weak
undetect
bind
observ
moulard
et
al
cosalan
inhibit
bind
well
fusion
viral
envelop
cell
membran
potent
rf
cemss
cell
vs
iiib
cell
santhosh
et
al
polygonum
tinctorium
use
extens
chines
japanes
folk
medicin
treatment
mani
infecti
diseas
believ
effect
detoxif
antipyrexia
antinocicept
extract
constitu
medicin
plant
tryptanthrin
shown
possess
antifung
cancer
chemoprevent
antibacteri
activ
honda
tabata
koyamiyata
et
al
kataoka
et
al
miyak
et
al
pigment
ptp
antianaphylact
activ
kim
et
al
studi
report
first
time
potent
activ
aqueou
extract
ferment
leav
polygonum
tinctorium
sukumo
extract
found
highli
select
vitro
sukumo
extract
suppress
product
inhibit
viral
entri
process
bind
viru
envelop
thu
prevent
hivinduc
syncytium
format
exceedingli
broad
therapeut
window
base
result
physicochem
analysi
antivir
activ
factor
put
novel
polyanion
highmolecularweight
compound
contain
phenol
substructur
aqueou
extract
sukumo
sukumo
collect
leav
polygonum
tinctorium
tokushima
japan
ferment
month
provid
identifi
dr
matsuda
voucher
specimen
deposit
institut
hemorheolog
function
food
co
ltd
hyogo
japan
sukumo
powder
g
reflux
three
time
ethanol
water
l
aqueou
solut
clarifi
filter
filter
highmolecular
compound
precipit
aqueou
extract
sukumo
ethanol
collect
centrifug
rpm
min
yield
g
antihiv
activ
sukumo
extract
test
store
c
use
cell
cell
chronic
infect
iii
b
strain
cultur
medium
supplement
fetal
bovin
serum
fb
cansera
intern
inc
canada
antibiot
gml
gml
streptomycin
vero
stabli
express
ho
cell
maintain
dulbecco
modifi
eagl
medium
dmem
contain
supplement
iii
b
prepar
propag
cell
molecular
clone
strain
strain
jrcsf
prepar
transfect
cell
jrcsf
plasmid
carri
fulllength
provir
dna
cultur
supernat
clarifi
filter
frozen
c
herp
simplex
viru
type
propag
vero
cell
kindli
provid
dr
shaku
cellfre
viru
stock
prepar
sonic
hsvinfect
vero
cell
skim
milk
store
c
use
determin
activ
cytotox
sukumo
extract
cell
either
infect
iii
b
strain
multipl
infect
moi
uninfect
mock
infect
cell
viabil
quantifi
mtt
dojindo
kumamoto
japan
assay
cell
ec
valu
calcul
infect
cell
effect
cc
valu
calcul
uninfect
cell
drug
cytotox
ichiyama
et
al
peripher
blood
mononuclear
cell
pbmc
donor
isol
ficollhypaqu
densiti
gradient
centrifug
pha
gml
sigmaaldrich
uml
shionogi
osaka
japan
activ
pbmc
infect
h
ng
gag
presenc
absenc
sukumo
extract
gml
wash
three
time
pb
cultur
day
fb
plu
uml
without
sukumo
extract
gag
cultur
supernat
determin
autom
enzymelink
immunosorb
assay
eilsa
fuji
rebio
inc
tokyo
japan
assay
antigen
zeptometrix
buffalo
new
york
use
standard
chronic
iii
b
infect
cell
cocultur
hiv
noninfect
cell
ratio
c
day
presenc
test
compound
grade
concentr
cellcel
fusion
analyz
confoc
microscop
assess
syncytium
format
sukumo
extract
also
test
inhibitor
replic
vero
cell
use
standard
plaqu
assay
two
hour
treatment
sukumo
extract
vero
cell
subject
infect
pfu
absenc
presenc
serial
dilut
sukumo
extract
cultur
medium
supplement
fb
human
gml
sigmaaldrich
antibiot
without
compound
cultur
day
cell
stain
giemsa
solut
number
viral
plaqu
calcul
percentag
test
control
order
determin
percent
inhibit
ec
valu
concentr
compound
inhibit
viral
replic
rel
control
human
cell
suspend
fresh
medium
presenc
absenc
variou
concentr
sukumo
extract
c
h
wash
cell
incub
ng
gag
h
ice
c
absenc
presenc
extract
cell
wash
fb
pellet
resuspend
l
lysi
buffer
pb
contain
bsa
level
gag
quantifi
autom
elisa
system
cell
pretreat
normal
human
igg
zyme
south
san
francisco
mgml
pb
contain
fb
buffer
min
ice
block
fc
receptor
treat
antibodi
gml
r
system
inc
antibodi
gml
biosciencespharmingen
san
diego
presenc
absenc
sukumo
extract
c
h
cell
wash
fb
strain
fitcconjug
antimous
igg
mgml
american
qualex
min
ice
pretreat
cell
also
stain
fitcconjug
antihuman
monoclon
mous
antibodi
isotyp
igg
neg
control
flow
cytometri
dilut
dako
cell
fix
paraformaldehydepb
solut
analyz
fac
calibur
becton
dickinson
flow
cytomet
cellquest
softwar
becton
dickinson
pseudotyp
vesicular
stomat
viru
protein
g
vsvg
onto
hiv
core
envdefect
report
viru
carri
follow
plasmid
dna
g
encod
envelop
vsvg
cotransfect
pnle
env
nef
g
cell
use
calcium
phosphat
method
viru
titer
determin
base
level
gag
time
cours
assay
conduct
determin
step
viral
infect
entri
postentri
inhibit
sukumo
extract
three
treatment
schedul
appli
infect
cell
infect
pseudotyp
virus
ngml
gag
amount
gag
cultur
supernat
determin
assess
replic
sukumo
extract
use
serial
concentr
rang
gml
ad
differ
time
level
gag
determin
day
incub
autoelisa
system
bind
assay
use
determin
affin
sukumo
extract
virion
viral
replic
assay
separ
sukumo
extract
viru
carri
chromatographi
gel
filtrat
system
column
sephacryl
cm
amersham
pharmacia
biotech
sweden
column
equilibr
compound
elut
column
pb
sampl
separ
follow
three
sampl
sukumo
extract
control
l
sukumo
extract
mgml
l
medium
contain
fb
ad
viru
control
l
pb
l
cultur
supernat
contain
ad
sukumo
extractviru
mixtur
l
sukumo
extract
l
cultur
supernat
contain
ad
volum
l
sampl
inject
onto
analyt
column
incub
c
h
one
fraction
eluant
collect
ml
ice
elut
peak
sukumo
extract
control
fraction
wavelength
nm
iiib
activ
mtt
assay
monitor
determin
elut
posit
sukumo
extract
fig
level
gag
elut
fraction
measur
autoelisa
determin
elut
posit
viru
fig
viral
infect
analyz
elut
fraction
viru
control
sukumo
extractviru
mixtur
select
fraction
clarifi
filter
cell
ml
infect
mixtur
elut
fraction
two
hour
infect
cell
wash
ad
fresh
fb
medium
cultur
day
gag
supernat
measur
anion
exchang
chromatographi
carri
deaesephacel
column
equilibr
phosphat
buffer
ph
bound
sampl
elut
stepwis
increas
nacl
concentr
phosphat
buffer
elut
fraction
analyz
antihiv
activ
use
mtt
assay
method
sukumo
extract
also
separ
sdspage
gel
stain
silver
reagent
cut
describ
fig
sukumo
reextract
medium
sdsgel
fraction
collect
supernat
activ
activ
sukumo
extract
first
investig
convent
mtt
assay
use
cell
sukumo
extract
complet
inhibit
iii
b
strain
replic
cell
concentr
low
gml
effect
concentr
ec
ec
gml
respect
cytotox
concentr
cc
found
gml
fig
select
index
ratio
cc
ec
sukumo
extract
indic
compound
potent
select
sukumo
extract
also
evalu
inhibit
wildtyp
herp
simplex
replic
infect
vero
cell
use
standard
viral
plaqu
assay
fig
sukumo
extract
exhibit
antivir
activ
ec
valu
gml
howev
inhibitori
activ
observ
influenza
viru
polioviru
sar
viru
sukumo
extract
test
concentr
rang
gml
data
shown
sukumo
extract
inhibit
varieti
isol
includ
laboratori
adapt
isol
iiib
strain
laboratori
molecular
clone
type
type
jrcsf
varieti
cell
includ
jurkat
express
ho
cell
data
shown
inhibitori
activ
sukumo
extract
jrcsf
replic
pbmc
also
demonstr
phastimul
pbmc
infect
h
c
absenc
presenc
gml
sukumo
extract
follow
wash
ml
infect
cell
per
well
seed
plate
incub
day
absenc
presenc
appropri
concentr
compound
quantiti
gag
measur
autoelisa
system
assay
cultur
supernat
cell
infect
virus
exhibit
ec
valu
gml
respect
fig
gag
level
untreat
sampl
jrcsf
ngml
respect
replic
cell
appear
sensit
sukumo
extract
pbmc
variou
step
life
cycl
next
investig
step
sukumo
extract
exert
effect
antagonist
determin
whether
viral
bind
cell
target
sukumo
extract
bind
assay
carri
measur
effect
sukumo
extract
virionscel
surfac
interact
cell
mix
viru
ice
h
cell
wash
remov
unbound
virus
result
demonstr
sukumo
extract
block
viruscel
bind
ec
gml
fig
inhibitori
effect
sukumo
extract
entri
cell
also
studi
cell
cell
incub
viru
c
h
treat
trypsin
remov
bound
virion
intracellular
gag
measur
sukumo
extract
inhibit
viral
entri
ec
gml
fig
bind
entri
cell
effici
inhibit
sukumo
extract
dosedepend
manner
similar
result
also
observ
type
jrcsf
cell
data
shown
experi
show
good
correl
antihiv
activ
inhibitori
activ
viru
bindingentri
induc
sukumo
extract
sukumo
extract
also
complet
prevent
syncytium
format
cocultur
cell
concentr
gml
effici
prevent
even
gml
fig
data
indic
sukumo
extract
exert
effect
initi
step
infect
viral
entri
membran
fusion
target
cell
analyz
chang
express
cell
express
cell
upon
treatment
differ
concentr
sukumo
extract
high
concentr
sukumo
extract
gml
caus
downexpress
control
sukumo
extract
use
concentr
gml
level
express
control
respect
contrast
level
express
surfac
ho
cell
control
concentr
rang
fig
determin
sukumo
extract
interact
appli
chromatograph
analysi
use
sephacryl
separ
viru
particl
sukumo
extract
base
differenti
molecular
size
sukumo
extract
fraction
main
activ
elut
fraction
reveal
mtt
assay
elut
fraction
select
infect
cell
h
c
wash
cell
incub
day
gag
cultur
supernat
measur
autoelisa
fig
hand
elut
fraction
shown
assay
fig
left
excess
amount
sukumo
extract
mix
separ
sephacryl
viral
peak
detect
fraction
fig
right
antihiv
activ
still
observ
fraction
data
shown
see
whether
fraction
contain
infect
capac
amount
gag
assess
supernat
cell
infect
use
volum
l
elut
fraction
viral
control
contain
ng
antigen
sukumo
extractviru
mixtur
contain
ng
antigen
infect
cell
respect
shown
fig
fraction
obtain
viral
control
exhibit
high
activ
ngml
level
day
infect
fraction
sukumo
extractviru
mixtur
level
low
ngml
respect
result
strongli
suggest
sukumo
extract
specif
bound
viral
particl
effici
trap
viral
particl
viral
infect
significantli
abrog
due
blockag
entri
cell
although
data
provid
evid
entri
could
primari
antivir
target
sukumo
extract
still
remain
possibl
sukumo
extract
exert
effect
late
step
viral
replic
address
time
cours
assay
perform
use
singl
cycl
infect
vsvg
pseudotyp
cell
gag
supernat
measur
day
postinfect
result
show
dosedepend
antivir
activ
sukumo
extract
observ
ad
time
b
entri
step
contrast
inhibit
seen
sukumo
extract
ad
time
pretreat
time
c
step
postentri
concentr
studi
rang
gml
fig
similar
result
also
observ
cell
use
data
shown
result
suggest
sukumo
extract
affect
earli
step
postentri
step
viral
life
cycl
base
studi
conclud
persuas
eviden
sukumo
extract
bind
inhibitor
interfer
virioncel
interact
inhibit
like
mediat
bind
viral
envelop
antivir
factor
extract
sukumo
use
organ
solvent
water
inhibitori
activ
found
aqueou
extract
crude
sukumo
extract
fraction
deaesephacel
column
chromatographi
main
fraction
antivir
activ
elut
column
nacl
fig
sukumo
extract
also
separ
use
sdspage
activ
detect
fraction
sdsgel
extract
correspond
molecular
weight
fig
ga
chromatographi
analysi
acid
hydrolys
sukumo
extract
reveal
carbohydr
content
ara
xyl
man
gal
glc
tabl
sdspagepa
stain
yield
bright
red
band
zachariu
et
al
data
shown
element
analysi
reveal
sulfer
content
fig
effect
sukumo
extract
vsvg
pseudotyp
replic
cell
infect
nle
strain
lack
env
nef
vsvg
envelop
pesudotyp
viru
gml
sukumo
extract
use
activ
determin
day
later
measur
gag
treatment
preentri
step
cell
incub
sukumo
extract
h
c
wash
exposur
viru
cell
infect
incub
absenc
sukumo
extract
treatment
b
entri
step
cell
expos
viru
presenc
sukumo
extract
h
sukumo
extract
unabsorb
virus
remov
wash
cell
incub
absenc
sukumo
extract
treatment
c
postentri
step
cell
infect
viru
h
unabsorb
viru
remov
incub
presenc
sukumo
extract
sukumo
extract
tabl
antivir
factor
sukumo
extract
stabl
wide
rang
ph
condit
shown
tabl
antivir
activ
sukumo
extract
reduc
treatment
h
hcl
naio
valu
ec
gml
somewhat
decreas
treat
naoh
activ
also
lost
heat
c
min
inactiv
proteas
trypsin
proteinas
k
pronas
digest
final
address
whether
activ
sukumo
extract
heparin
dextran
sulfat
abrog
treat
acid
sukumo
extract
boil
c
h
hcl
h
effect
concentr
ec
essenti
unaffect
sharp
contrast
heparin
boil
c
h
h
dextran
sulfat
hcl
h
effect
concentr
gml
mtt
assay
untreat
sampl
gml
respect
tabl
sukumo
extract
potent
select
inhibit
replic
vitro
compound
also
evalu
activ
variou
viru
speci
without
envelop
includ
vesicular
stomat
viru
g
protein
envelop
pseudotyp
type
viru
wherea
sukumo
extract
activ
herp
simplex
viru
devoid
activ
influenza
viru
sar
viru
nonenvelop
polioviru
base
current
knowledg
hiv
sever
stage
viral
life
cycl
potenti
vulner
inhibitor
divid
entri
step
postentri
step
studi
demonstr
sever
differ
techniqu
sukumo
extract
inhibit
infecti
process
cell
entri
step
data
present
fig
indic
sukumo
extract
abl
block
viral
bind
target
cell
inhibit
virusinduc
cellcel
fusion
furthermor
timecours
experi
show
full
protect
activ
sukumo
extract
achiev
compound
present
viru
adsorpt
period
none
effect
seen
compound
incub
cell
prior
viral
infect
also
extract
suppress
viral
replic
viru
enter
cell
thu
sukumo
extract
interfer
earli
event
viru
replic
cycl
presum
viral
adsorpt
step
two
class
cell
surfac
molecul
chemokin
receptor
well
often
view
hiv
coreceptor
mediat
entri
found
downmodul
receptor
coreceptor
target
cell
induc
sukumo
extract
howev
inhibitori
activ
rather
weak
addit
activ
sukumo
extract
lost
cell
wash
prior
addit
antibodi
indic
compound
weakli
associ
cell
surfac
therefor
result
perfectli
explain
sukumo
extract
abl
block
viru
entri
hiv
effici
especi
viru
effect
sukumo
extract
viral
bind
process
assess
directli
use
chromatographi
method
fig
result
show
sukumo
extract
bound
separ
along
larger
viru
particl
fraction
gel
filtrat
column
studi
hypothes
sukumo
extract
exert
antihiv
activ
bind
viral
envelop
glycoprotein
result
prevent
viru
attach
cell
surfac
receptor
coreceptor
wherebi
interfer
earli
adsorpt
entri
hiv
replic
cycl
find
consist
hypothesi
sukumo
extract
interfer
virion
rather
cell
function
might
also
explain
sukumo
extract
less
toxic
target
cell
vitro
biochem
featur
water
extract
sukumo
prepar
polygonum
tinctorium
select
inhibit
replic
studi
antivir
activ
extract
sukumo
varieti
way
use
water
organ
solvent
hexan
chloroform
aceton
ethanol
inhibitori
activ
found
aqueou
extract
wherea
extract
organ
solvent
show
antihiv
activ
indigo
stain
ingredi
tryptanthrin
low
molecular
weight
compon
polygonum
tinctorium
also
exihibit
antihiv
activ
data
shown
main
fraction
antihiv
activ
elut
deaesephacel
column
neg
ionexchang
column
higher
molar
nacl
result
indic
activ
factor
highli
anion
also
confirm
antihiv
compound
consist
phenol
substructur
fecl
k
fe
cn
stain
barton
et
al
data
shown
polysaccharid
contain
sulfur
atom
sugar
analysi
element
analysi
respect
tabl
factor
estim
high
molecular
weight
compound
sephadex
gelfiltr
analysi
data
shown
sdsgel
sukumo
extract
fig
protein
detect
water
extract
sukumo
sdspagesilv
stain
data
confirm
observ
inhibitori
activ
sukumo
extract
inactiv
proteas
digest
heat
c
min
furthermor
boil
sukumo
extract
presenc
hcl
h
naoh
h
result
loss
activ
similarli
inactiv
naio
treatment
nakashima
et
al
break
carbohydr
tabl
suggest
sugar
backbon
essenti
antihiv
activ
sukumo
extract
pharmaceut
valu
sukumo
extract
like
enhanc
stabil
wide
rang
ph
valu
shown
heat
c
min
treatment
acid
alkalin
condit
sinc
activ
sukumo
higher
fresh
leav
data
shown
possibl
activ
substanc
deriv
bacteria
could
exclud
compar
differ
repres
sulfat
polysaccharid
sukumo
extract
suscept
acid
treatment
effect
clearli
abrog
treatment
case
dextran
sulfat
heparin
sukumo
extract
tabl
activ
heparin
complet
destroy
h
treatment
case
hcl
treatment
dextran
sulfat
unlik
epigallocatechin
gallat
polyphenol
substanc
green
tea
suzutani
et
al
yamaguchi
et
al
sukumo
extract
exert
activ
postviru
entri
process
work
character
sukumo
extract
potenc
antivir
candid
drug
progress
